DGHS, Union Health Ministry, along with experts reviews the Chandipura virus cases and Acute Encephalitis Syndrome cases in Gujarat, Rajasthan, and Madhya Pradesh
Prof (Dr) Atul Goel, DGHS, Union Health Ministry, and Director of NCDC, along with experts from AIIMS, Kalawati Saran Children’s Hospital, and National Institute of Mental Health & Neurosciences (NIMHANS), as well as officials from Central and State surveillance units, reviewed the Chandipura virus and Acute Encephalitis Syndrome (AES) cases in Gujarat, Rajasthan, and Madhya […]
Union Health Minister Shri J P Nadda chairs a Training and Awareness Program for 1,000 Street Food Vendors by FSSAI in the presence of Smt. Anupriya Patel, Union MoS for Health and Family Welfare
Union Health Minister, Shri Jagat Prakash Nadda chaired a training and awareness program for 1,000 street food vendors conducted by the Food Safety and Standards Authority of India (FSSAI) in Vigyan Bhawan, here today. He was joined by Smt. Anupriya Patel, Union Minister of State for Health and Family Welfare. Highlighting the importance of street […]
New data for Roche’s Susvimo demonstrates sustained efficacy in two serious diabetic eye conditions
Two-year Phase III data presented at ASRS 2024 show Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema (DME) and diabetic retinopathy (DR) Safety data were consistent with the known safety profile for Susvimo in people with DME and DR Additionally, the US FDA has accepted the filing application for Susvimo […]
Roche’s Vabysmo showed extended durability, continued efficacy and a consistent safety profile in long-term diabetic macular edema (DME) study
More than 90% of patients had absence of DME after four years in a pre-specified exploratory endpoint People treated with Vabysmo sustained vision gains and anatomical improvements, with almost 80% receiving treatment at intervals of three or four months, in an exploratory analysis The study met all primary endpoints, showing safety data were consistent with […]
Union Health Minister Shri J P Nadda reviews Regulation of Drugs, Cosmetics and Medical Devices
“For India to become the global leader in drugs regulation to match our global reputation of ‘Pharmacy of the World’, we need to have world class regulatory framework matching our scale of operations and international expectations”. This was stated by Union Health Minister Shri J P Nadda, as he reviewed the regulation of drugs, cosmetics […]
Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity
After four weeks of treatment, CT-996 demonstrated clinically meaningful weight loss of -7.3% (weight loss in placebo -1.2%; p < 0.001) Pharmacokinetic data supports a once-daily oral dosing regimen for CT-996 The safety and tolerability profile was consistent with other oral GLP-1 receptor agonists and no unexpected safety signals were observed Basel, 17 July 2024 […]
WHO releases report on state of development of antibacterials
14 June 2024 Geneva, Switzerland: The World Health Organization (WHO) today released its latest report on antibacterial agents, including antibiotics, in clinical and preclinical development worldwide. Although the number of antibacterial agents in the clinical pipeline increased from 80 in 2021 to 97 in 2023, there is a pressing need for new, innovative agents for […]
Union Health Minister Shri J P Nadda chairs high level meeting on attaining targeted Health goals in the first 100 days of formation of new Government
Shri Jagat Prakash Nadda, Union Minister for Health and Family Welfare chaired a high-level meeting on attaining targeted Health goals in the first 100 days of formation of new Government, with senior officials of the Union Health Ministry, here today. He was joined by Smt. Anupriya Patel and Shri Jadhav Prataprao Ganpatrao, Union Ministers of […]
Existing District/Referral Hospitals being converted into Medical Colleges shall continue their roles and obligations under NHM and will continue to receive funding support from the Center
In view of demands made by certain States/UTs for construction of additional District/Referral hospitals (DH/RH) due to apprehension that the existing DH/RH which are being converted into Medical Colleges will stop receiving funding from NHM, Union Health Secretary Shri Apurva Chandra has written to States/UTs clarifying that all existing DH/RH which are being converted into […]
European Commission approves Roche’s fixed-duration Columvi (glofitamab) for people with relapsed or refractory diffuse large B-cell lymphoma
Columvi is the first CD20xCD3 T-cell-engaging bispecific antibody available in Europe to treat the most common and aggressive form of lymphoma Approval is based on results from the phase I/II NP30179 study, where Columvi given as a fixed course induced early and long-lasting complete responses in people with heavily pre-treated or refractory diffuse large B-cell […]
